Zealand Pharma Increases Share Capital By DKK 150,317 Through Issuance of 150,317 New Shares

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Copenhagen, Denmark, December 11, 2025 – Zealand Pharma A/S ("Zealand Pharma") (NASDAQ:ZEAL) (CVR-no. 20 04 50 78),), a biotechnology company transforming the future of metabolic health, has by decision of the Board of Directors increased its share capital by a nominal amount of DKK 150,317 divided into 150,317 new shares with a nominal value of DKK 1 each. The capital increase is a consequence of the exercise of warrants granted under two of Zealand Pharma's employee warrant programs.